Pergamum AB Announces a Strategic Collaboration with Cadila Pharmaceuticals

News   Feb 11, 2013

 
Pergamum AB Announces a Strategic Collaboration with Cadila Pharmaceuticals
 
 
 

RELATED ARTICLES

New Strategy for Multiple Myeloma Immunotherapy

News

Osaka University study unveils new target for monoclonal antibody-based treatment of cancer.

READ MORE

Meningococcal Vaccine Could Protect Against 91% of Targeted Bacterial Strains

News

“We are very pleased to see that it looks like the vaccine has the potential to cover most of the strains of meningococcal Group B bacteria currently circulating in the U.S.,” said lead study author Gowrisankar Rajam, Ph.D.

READ MORE

AIDS Vaccine Design: New Data Offers Important Insight

News

New data published in Immunity further illuminate how some human beings generate powerful, HIV-blocking antibodies. The results offer important insight into a potential AIDS vaccine design.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE